69 related articles for article (PubMed ID: 7122527)
1. Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension.
Barrett RJ; Lokhandwala MF
Proc West Pharmacol Soc; 1982; 25():39-42. PubMed ID: 7122527
[No Abstract] [Full Text] [Related]
2. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
Hahn RA; MacDonald BR; Martin MA
J Pharmacol Exp Ther; 1983 Jan; 224(1):206-14. PubMed ID: 6848744
[No Abstract] [Full Text] [Related]
6. Dopaminergic inhibition of cardiac sympathetic nerve function by pergolide.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1982 Jan; 77(1):79-83. PubMed ID: 6277657
[TBL] [Abstract][Full Text] [Related]
7. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
Rosenkranz RP; McClelland DL
Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
[No Abstract] [Full Text] [Related]
8. The role of central dopamine (DA) receptors in the regulation of blood pressure.
Jaszlits L; Tardos L; Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):405-10. PubMed ID: 4070082
[TBL] [Abstract][Full Text] [Related]
9. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Fuller RW; Clemens JA; Hynes MD
J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
[TBL] [Abstract][Full Text] [Related]
10. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
Jiang DH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
[No Abstract] [Full Text] [Related]
11. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II: Sites and mechanisms of action of dopamine receptor agonists.
Cavero I; Massingham R; Lefèvere-Borg F
Life Sci; 1982 Sep; 31(11):1059-69. PubMed ID: 6755118
[TBL] [Abstract][Full Text] [Related]
12. Involvement of central dopamine receptors in the hypotensive action of pergolide.
Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
[TBL] [Abstract][Full Text] [Related]
13. The 'presynaptic' blocking potency of sulpiride and haloperidol in the rat is age-dependent.
Ogren SO; Rodebjer A; Angeby K
Neurosci Lett; 1984 May; 46(2):203-7. PubMed ID: 6738914
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides.
Kohli JD; Glock D; Goldberg LI
Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064
[No Abstract] [Full Text] [Related]
15. Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists.
Begaud B; Dang Tran L; Montastruc JL; Montastruc P
Fundam Clin Pharmacol; 1987; 1(3):153-9. PubMed ID: 3428838
[TBL] [Abstract][Full Text] [Related]
16. Proposed dopaminergic pharmacophore of lergotrile, pergolide, and related ergot alkaloid derivatives.
Cannon JG; Demopoulos BJ; Long JP; Flynn JR; Sharabi FM
J Med Chem; 1981 Mar; 24(3):238-40. PubMed ID: 6115056
[No Abstract] [Full Text] [Related]
17. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
18. Pergolide: a potent dopaminergic antihypertensive.
Yen TT; Stamm NB; Clemens JA
Life Sci; 1979 Jul; 25(3):209-15. PubMed ID: 39213
[No Abstract] [Full Text] [Related]
19. Inhibitory effects of pergolide on peripheral adrenergic neurotransmission in spontaneously hypertensive rats.
Hahn RA
Life Sci; 1981 Dec; 29(24):2501-9. PubMed ID: 6275226
[No Abstract] [Full Text] [Related]
20. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Yoshimura N; Mizuta E; Yoshida O; Kuno S
J Pharmacol Exp Ther; 1998 Jul; 286(1):228-33. PubMed ID: 9655864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
